Literature DB >> 26707344

MR Angiography of Renal Transplant Vasculature with Ferumoxytol:: Comparison of High-Resolution Steady-State and First-Pass Acquisitions.

Michael T Corwin1, Ghaneh Fananapazir2, Abhijit J Chaudhari2.   

Abstract

RATIONALE AND
OBJECTIVES: This work aimed to quantify the differences in signal-to-noise ratio (SNR) and vessel sharpness between steady-state and first-pass magnetic resonance angiography (MRA) with ferumoxytol in renal transplant recipients.
MATERIALS AND METHODS: We performed a retrospective study of adult patients who underwent steady-state and first-pass MRA with ferumoxytol to evaluate renal transplant vasculature. SNR was calculated in the external iliac artery, and vessel sharpness was calculated in the external iliac and renal transplant arteries for both acquisitions. Data were compared using Student's t test.
RESULTS: Fifteen patients were included (mean age 56.9 years, 10 males). The mean SNR of the external iliac artery was 42.2 (SD, 11.9) for the first-pass MRA and 41.8 (SD, 9.7) for the steady-state MRA (p = 0.92). The mean vessel sharpness was significantly higher for the steady-state MRA compared to first-pass MRA for both external iliac (1.24 vs. 0.80 mm(-1), p < 0.01) and renal transplant arteries (1.26 vs. 0.79 mm(-1), p < 0.01).
CONCLUSION: Steady-state MRA using ferumoxytol improves vessel sharpness while maintaining equivalent SNR compared to conventional first-pass MRA in renal transplant patients.
Copyright © 2015 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MRA; Steady state; contrast; ferumoxytol; nephrotoxicity; renal transplant

Mesh:

Substances:

Year:  2015        PMID: 26707344      PMCID: PMC4855839          DOI: 10.1016/j.acra.2015.10.021

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  17 in total

1.  Doppler-ultrasound measurements in renal allografts depend on the patient's body position.

Authors:  Dominik Steubl; Evangelos Papachristou; Petra Wolf; Marcel Roos; Jens Lutz; Uwe Heemann; Konrad F Stock
Journal:  Vasa       Date:  2012-03       Impact factor: 1.961

2.  Renal transplant: nonenhanced renal MR angiography with magnetization-prepared steady-state free precession.

Authors:  Xin Liu; Natasha Berg; John Sheehan; Xiaoming Bi; Peter Weale; Renate Jerecic; James Carr
Journal:  Radiology       Date:  2009-03-04       Impact factor: 11.105

3.  Vascular artifact mimicking thrombosis on MR imaging using ferumoxytol as a contrast agent in abdominal vascular assessment.

Authors:  Ghaneh Fananapazir; Daniele Marin; Paul V Suhocki; Charles Y Kim; Mustafa R Bashir
Journal:  J Vasc Interv Radiol       Date:  2014-03-14       Impact factor: 3.464

4.  Vascular Imaging With Ferumoxytol as a Contrast Agent.

Authors:  Michael D Hope; Thomas A Hope; Chengcheng Zhu; Farshid Faraji; Henrik Haraldsson; Karen G Ordovas; David Saloner
Journal:  AJR Am J Roentgenol       Date:  2015-06-23       Impact factor: 3.959

5.  FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease.

Authors:  Min Lu; Martin H Cohen; Dwaine Rieves; Richard Pazdur
Journal:  Am J Hematol       Date:  2010-05       Impact factor: 10.047

Review 6.  Imaging of the renal transplant: comparison of MRI with duplex sonography.

Authors:  R F J Browne; D J Tuite
Journal:  Abdom Imaging       Date:  2006 Jul-Aug

7.  Management of transplant renal artery stenosis.

Authors:  Dheeraj K Rajan; S William Stavropoulos; Richard D Shlansky-Goldberg
Journal:  Semin Intervent Radiol       Date:  2004-12       Impact factor: 1.513

8.  Depiction of transplant renal vascular anatomy and complications: unenhanced MR angiography by using spatial labeling with multiple inversion pulses.

Authors:  Hao Tang; Zi Wang; Liang Wang; Xiaomeng Hu; Qiuxia Wang; Zhen Li; Jianjun Li; Xiaoyan Meng; Yanchun Wang; Daoyu Hu
Journal:  Radiology       Date:  2014-03-03       Impact factor: 11.105

Review 9.  Emerging applications for ferumoxytol as a contrast agent in MRI.

Authors:  Mustafa R Bashir; Lubna Bhatti; Daniele Marin; Rendon C Nelson
Journal:  J Magn Reson Imaging       Date:  2014-06-30       Impact factor: 4.813

10.  Non-contrast enhanced 3D SSFP MRA of the renal allograft vasculature: a comparison between radial linear combination and Cartesian inflow-weighted acquisitions.

Authors:  Eric M Bultman; Jessica Klaers; Kevin M Johnson; Christopher J François; Mark L Schiebler; Scott B Reeder; Walter F Block
Journal:  Magn Reson Imaging       Date:  2013-10-15       Impact factor: 3.130

View more
  8 in total

Review 1.  Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.

Authors:  Seyed Mohammadali Dadfar; Karolin Roemhild; Natascha I Drude; Saskia von Stillfried; Ruth Knüchel; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2019-01-11       Impact factor: 15.470

2.  Non-contrast-enhanced magnetic resonance angiography: a reliable clinical tool for evaluating transplant renal artery stenosis.

Authors:  Long Jiang Zhang; Jin Peng; Jiqiu Wen; U Joseph Schoepf; Akos Varga-Szemes; L Parkwood Griffith; Yuan Meng Yu; Shu Min Tao; Yan Jun Li; Xue Feng Ni; Jian Xu; Dong Hong Shi; Guang Ming Lu
Journal:  Eur Radiol       Date:  2018-04-17       Impact factor: 5.315

3.  Contrast-enhanced MR Angiography without Gadolinium-based Contrast Material: Clinical Applications Using Ferumoxytol.

Authors:  Mohammad H Jalili; Tiffany Yu; Cameron Hassani; Ashley E Prosper; J Paul Finn; Arash Bedayat
Journal:  Radiol Cardiothorac Imaging       Date:  2022-08-04

Review 4.  Vascular applications of ferumoxytol-enhanced magnetic resonance imaging of the abdomen and pelvis.

Authors:  Andrew W Bowman; Cory R Gooch; Lauren F Alexander; Madhura A Desai; Candice W Bolan
Journal:  Abdom Radiol (NY)       Date:  2020-10-22

5.  Acute effects of ferumoxytol on regulation of renal hemodynamics and oxygenation.

Authors:  Kathleen Cantow; Andreas Pohlmann; Bert Flemming; Fabienne Ferrara; Sonia Waiczies; Dirk Grosenick; Thoralf Niendorf; Erdmann Seeliger
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

6.  Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease.

Authors:  Sokratis Stoumpos; Martin Hennessy; Alex T Vesey; Aleksandra Radjenovic; Ram Kasthuri; David B Kingsmore; Patrick B Mark; Giles Roditi
Journal:  Eur Radiol       Date:  2019-03-27       Impact factor: 5.315

7.  Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients.

Authors:  Sokratis Stoumpos; Martin Hennessy; Alex T Vesey; Aleksandra Radjenovic; Ram Kasthuri; David B Kingsmore; Patrick B Mark; Giles Roditi
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

8.  Experimental MRI Monitoring of Renal Blood Volume Fraction Variations En Route to Renal Magnetic Resonance Oximetry.

Authors:  Andreas Pohlmann; Kathleen Cantow; Till Huelnhagen; Dirk Grosenick; Joāo Dos Santos Periquito; Laura Boehmert; Thomas Gladytz; Sonia Waiczies; Bert Flemming; Erdmann Seeliger; Thoralf Niendorf
Journal:  Tomography       Date:  2017-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.